Optomed
Optomed: Time for a Breakthrough (Redeye)
2020-05-26 07:00
Redeye initiates coverage of Optomed with a base case of EUR 8 per share. Optomed is an innovative company designing and selling handheld cameras and software solutions for eyesight examination. Our analysis indicates that the stock is greatly undervalued.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se